Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial

Molecular engineering tools for the development of vaccines against infectious diseases: current status and future directions

In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives

Neutralizing antibodies against EBV gp42 show potent <i>in vivo</i> protection and define novel epitopes

System Design and Clinical Validation of Intelligent Nucleic Acid POCT for Ultra-High Sensitivity SARS-CoV-2 Detection within 30 Min

Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

MHC class II regulation of CD8+T cell tolerance and implications in autoimmunity and cancer immunotherapy

Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection

Anti-BNLF2b Screening for Nasopharyngeal Cancer

Head-to-head immunogenicity comparison of an<i> Escherichia</i> coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors

Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant

The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study

Reconsideration of Maternal Serological Testing for Predicting Congenital CMV Infection

All-in-one microfluidic chip for 30-min quantitative point-of-care-testing of nucleic acids

Butyrate Protects against SARS-CoV-2-Induced Tissue Damage in Golden Hamsters

Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies

Nanoparticle-based multivalent human antibodies offer potent and broad neutralization against Omicron sublineages

Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Risedronate-Functionalized Manganese-Calcium Phosphate Nanoparticles: A Potent Adjuvant for Subunit Vaccines and Cancer Immunotherapy

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters

Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency

Structure and proposed DNA delivery mechanism of a marine roseophage

Precision and correlation of ED50 and endpoint titer method in measuring HPV vaccine immunogenicity

Design of Multicomponent Peptide Fibrils with Ordered and Programmable Compositional Patterns

Design of Multicomponent Peptide Fibrils with Ordered and Programmable Compositional Patterns

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice

Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections

Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial

Ultra-fast, sensitive and low-cost real-time PCR system for nucleic acid detection

Safety and immunogenicity of an<i> Escherichia</i> coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial

Abnormally primed CD8 T cells: The Achilles' heel of CHB

A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19

Transcriptomics confirm the establishment of a liver-immune dual-humanized mouse model after transplantation of a single type of human bone marrow mesenchymal stem cell

Progress in immunotherapy

Ultrafast Microfluidic PCR Thermocycler for Nucleic Acid Amplification

Bacterial-Artificial-Chromosome-Based Genome Editing Methods and the Applications in Herpesvirus Research

All-in-One Microfluidic Chip for the Point-of-Care-Testing of Nucleic Acids: Combining a Dynamic-Seal Microvalve, Ultrasound-Assisted Reaction Chamber, and Slice Amplification with a Fluorescence Detection System

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for <i>Escherichia coli</i>-based vaccine design

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16

A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model

An Automated TW3-RUS Bone Age Assessment Method with Ordinal Regression-Based Determination of Skeletal Maturity

Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus

PointDE: Protein Docking Evaluation Using 3D Point Cloud Neural Network

Immunogenicity and safety of an<i> Escherichia</i> coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial